Metta V - Search Results

1

Personalised Advanced Therapies in Parkinson's Disease: The Role of Non-Motor Symptoms Profile.

Leta V, Dafsari HS, Sauerbier A, Metta V, Titova N, Timmermann L, Ashkan K, Samuel M, Pekkonen E, Odin P, Antonini A, Martinez-Martin P, Parry M, van Wamelen DJ, Ray Chaudhuri K. Leta V, et al. Among authors: metta v. J Pers Med. 2021 Aug 7;11(8):773. doi: 10.3390/jpm11080773. J Pers Med. 2021. PMID: 34442417 Free PMC article.

2

The possible clinical predictors of fatigue in Parkinson's disease: a study of 135 patients as part of international nonmotor scale validation project.

Metta V, Logishetty K, Martinez-Martin P, Gage HM, Schartau PE, Kaluarachchi TK, Martin A, Odin P, Barone P, Stocchi F, Antonini A, Chaudhuri KR. Metta V, et al. Parkinsons Dis. 2011;2011:125271. doi: 10.4061/2011/125271. Epub 2011 Dec 5. Parkinsons Dis. 2011. PMID: 22191065 Free PMC article.

3

Exploring hyperhidrosis and related thermoregulatory symptoms as a possible clinical identifier for the dysautonomic subtype of Parkinson's disease.

van Wamelen DJ, Leta V, Podlewska AM, Wan YM, Krbot K, Jaakkola E, Martinez-Martin P, Rizos A, Parry M, Metta V, Ray Chaudhuri K. van Wamelen DJ, et al. Among authors: metta v. J Neurol. 2019 Jul;266(7):1736-1742. doi: 10.1007/s00415-019-09325-w. Epub 2019 Apr 17. J Neurol. 2019. PMID: 30997572 Free PMC article.

4

Gastrointestinal dysfunction in Parkinson's disease: molecular pathology and implications of gut microbiome, probiotics, and fecal microbiota transplantation.

Metta V, Leta V, Mrudula KR, Prashanth LK, Goyal V, Borgohain R, Chung-Faye G, Chaudhuri KR. Metta V, et al. J Neurol. 2022 Mar;269(3):1154-1163. doi: 10.1007/s00415-021-10567-w. Epub 2021 Apr 21. J Neurol. 2022. PMID: 33881598 Review.

5

Cross-sectional analysis of the Parkinson's disease Non-motor International Longitudinal Study baseline non-motor characteristics, geographical distribution and impact on quality of life.

van Wamelen DJ, Sauerbier A, Leta V, Rodriguez-Blazquez C, Falup-Pecurariu C, Rodriguez-Violante M, Rizos A, Tsuboi Y, Metta V, Bhidayasiri R, Bhattacharya K, Borgohain R, Prashanth LK, Rosales R, Lewis S, Fung V, Behari M, Goyal V, Kishore A, Lloret SP, Martinez-Martin P, Chaudhuri KR. van Wamelen DJ, et al. Among authors: metta v. Sci Rep. 2021 May 5;11(1):9611. doi: 10.1038/s41598-021-88651-4. Sci Rep. 2021. PMID: 33953218 Free PMC article.

6

Parkinson's Disease: Personalized Pathway of Care for Device-Aided Therapies (DAT) and the Role of Continuous Objective Monitoring (COM) Using Wearable Sensors.

Metta V, Batzu L, Leta V, Trivedi D, Powdleska A, Mridula KR, Kukle P, Goyal V, Borgohain R, Chung-Faye G, Chaudhuri KR. Metta V, et al. J Pers Med. 2021 Jul 19;11(7):680. doi: 10.3390/jpm11070680. J Pers Med. 2021. PMID: 34357147 Free PMC article. Review.

7

Neurogenic and anti-inflammatory effects of probiotics in Parkinson's disease: A systematic review of preclinical and clinical evidence.

Leta V, Ray Chaudhuri K, Milner O, Chung-Faye G, Metta V, Pariante CM, Borsini A. Leta V, et al. Among authors: metta v. Brain Behav Immun. 2021 Nov;98:59-73. doi: 10.1016/j.bbi.2021.07.026. Epub 2021 Aug 5. Brain Behav Immun. 2021. PMID: 34364965 Review.

8

Tolerability of overnight rotigotine transdermal patch combined with intrajejunal levodopa infusion at 1 year: a 24-h treatment option in Parkinson's disease.

Lau YH, Leta V, Rukavina K, Parry M, Ann Natividad J, Metta V, Chung-Faye G, Chaudhuri KR. Lau YH, et al. Among authors: metta v. J Neural Transm (Vienna). 2022 Jul;129(7):889-894. doi: 10.1007/s00702-022-02506-4. Epub 2022 May 3. J Neural Transm (Vienna). 2022. PMID: 35503480 Free PMC article.

9

Real-life benefits of intrajejunal levodopa infusion therapy in four patients with the parkinsonian variant of progressive supranuclear palsy: A 1-year follow-up data report.

Metta V, Chaudhuri KR, Leta V, Mridula KR, Koduri C, Deepak S, Kalpala R, Reddy N, Chung-Faye G, Borgohain R. Metta V, et al. Brain Behav. 2022 Sep;12(9):e2547. doi: 10.1002/brb3.2547. Epub 2022 Aug 9. Brain Behav. 2022. PMID: 35943202 Free PMC article.

10

First Two-Year Observational Exploratory Real Life Clinical Phenotyping, and Societal Impact Study of Parkinson's Disease in Emiratis and Expatriate Population of United Arab Emirates 2019-2021: The EmPark Study.

Metta V, Ibrahim H, Loney T, Benamer HTS, Alhawai A, Almuhairi D, Al Shamsi A, Mohan S, Rodriguez K, Mohan J, O'Sullivan M, Muralidharan N, Al Mazrooei S, Dar Mousa K, Chung-Faye G, Mrudula R, Falup-Pecurariu C, Rodriguez Bilazquez C, Matar M, Borgohain R, Chaudhuri KR. Metta V, et al. J Pers Med. 2022 Aug 9;12(8):1300. doi: 10.3390/jpm12081300. J Pers Med. 2022. PMID: 36013249 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

41 results

Search Page